Skip to main content
Journal cover image

Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report

Publication ,  Journal Article
Liang, AL; Katebi Kashi, P; Hopkins, M; Beavis, A; Gaillard, S; Shih, IM; Fader, AN
Published in: Gynecologic Oncology Reports
November 1, 2021

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Gynecologic Oncology Reports

DOI

EISSN

2352-5789

Publication Date

November 1, 2021

Volume

38
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Liang, A. L., Katebi Kashi, P., Hopkins, M., Beavis, A., Gaillard, S., Shih, I. M., & Fader, A. N. (2021). Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report. Gynecologic Oncology Reports, 38. https://doi.org/10.1016/j.gore.2021.100877
Liang, A. L., P. Katebi Kashi, M. Hopkins, A. Beavis, S. Gaillard, I. M. Shih, and A. N. Fader. “Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report.” Gynecologic Oncology Reports 38 (November 1, 2021). https://doi.org/10.1016/j.gore.2021.100877.
Liang AL, Katebi Kashi P, Hopkins M, Beavis A, Gaillard S, Shih IM, et al. Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report. Gynecologic Oncology Reports. 2021 Nov 1;38.
Liang, A. L., et al. “Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report.” Gynecologic Oncology Reports, vol. 38, Nov. 2021. Scopus, doi:10.1016/j.gore.2021.100877.
Liang AL, Katebi Kashi P, Hopkins M, Beavis A, Gaillard S, Shih IM, Fader AN. Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report. Gynecologic Oncology Reports. 2021 Nov 1;38.
Journal cover image

Published In

Gynecologic Oncology Reports

DOI

EISSN

2352-5789

Publication Date

November 1, 2021

Volume

38